Pharma industry invests £377m in UK R&D collabs
ABPI chief said that the investment from companies is “excellent news at a time of economic uncertainty and signals the strength of the sector in the UK.”
Read More
Tag: industry
UCB to invest £1bn into UK under life sciences sector deal
The government has published the second Life Sciences Sector Deal, detailing both public and private sector investments into the sector, including a £1 billion investment in UK research and development by UCB.
Read More
UK to pursue deals and acquisitions despite Brexit uncertainty
The UK pharmaceutical industry is pressing ahead with M&A activity and is “geared to weather any disruption due to Brexit”, suggest results of a recent survey by EY.
Read More
Cultural shift needed to keep trust in health tech’s use of patient data
A new report from the Academy of Medical Sciences has claimed that a radical culture change is needed to ensure that the NHS can deliver the benefits of new health technologies that use patient data for care, whilst retaining public trust.
Read More
Huddersfield Uni launches pharma policy and practice research centre
The University of Huddersfield has launched the Centre for Pharmaceutical Policy and Practice Research, tasked with keeping the industry “armed with the latest research methods and advice”.
Read More
Health/industry groups react to Autumn Budget
Chancellor Philip Hammond’s Autumn Budget has promised an extra £2.8 billion for NHS services over the next three years, though the amount falls well short of the £4 billion deemed by health leaders as necessary to retain the current quality of services.
Read More
Report lays out new strategy for UK life sciences
Industry-led plans to breathe new life into the UK’s £64-billion life sciences sector have now been unveiled, alongside details of £160 million in government funding to fuel progress in the field.
Read More
Open innovation underpinning UK R&D, says ABPI
The search for new medicines in 2016 saw a continued increase in collaborative working between pharma companies and other firms, academia, and catapults, pushing further away from the closed innovation model of old, according to a new report by the Association of the British Pharmaceutical Industry.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
